11/30/23 16:05 | 11/28/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 6 | 0.6486 | 0 | 10 | 25 | 50 | D | | | | | | | | | | | | | | |
11/22/23 16:06 | 11/21/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 6 | 0.6383 | 0 | 10 | 33 | 40 | D | | | | | | | | | | | | | | |
11/20/23 20:14 | 11/16/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P.m | 18 | 0.6080 | 0 | 30 | New | 30 | D | | | | | | | | | | | | | | |
12/7/22 16:29 | 12/5/22 | PRDS | Pardes Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 14 | 1.09 | 0 | 13 | 33 | 50 | D | | | | | | | | | | | | | | |
12/5/22 16:21 | 12/1/22 | PRDS | Pardes Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P.m | 39 | 1.05 | 0 | 38 | New | 38 | D | | | | | | | | | | | | | | |
8/19/19 21:48 | 8/15/19 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 0 | 0.00 | 0 | 26 | 11 | 257 | D | | | | | | | | | | | | | | |
8/19/19 21:48 | 8/19/19 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P.d | 200 | 8.54 | 0 | 23 | 10 | 257 | D | | | | | | | | | | | | | | |
8/17/18 16:05 | 8/15/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 0 | 0.00 | 0 | 21 | 10 | 224 | D | | | | | | | | | | | | | | |
7/9/18 18:57 | 7/9/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 10.00 | 0 | 12 | 6 | 211 | D | | | | | | | | | | | | | | |
7/2/18 17:04 | 7/2/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 8.71 | 0 | 14 | 7 | 199 | D | | | | | | | | | | | | | | |
6/25/18 17:40 | 6/25/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 9.84 | 0 | 12 | 7 | 185 | D | | | | | | | | | | | | | | |
6/18/18 16:19 | 6/18/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 10.10 | 0 | 12 | 7 | 173 | D | | | | | | | | | | | | | | |
5/16/18 18:43 | 5/15/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 10 | 0.9860 | 0 | 10 | 7 | 161 | D | | | | | | | | | | | | | | |
12/22/17 16:16 | 12/21/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 6 | 1.22 | 0 | 5 | 3 | 150 | D | | | | | | | | | | | | | | |
12/15/17 16:36 | 12/13/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 5 | 0.9860 | 0 | 5 | 4 | 145 | D | | | | | | | | | | | | | | |
12/15/17 16:36 | 12/13/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -138 | 27.51 | 0 | -5 | -3 | 145 | D | | | | | | | | | | | | | | |
11/3/17 17:19 | 11/2/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 5 | 0.9860 | 0 | 5 | 4 | 145 | D | | | | | | | | | | | | | | |
11/3/17 17:19 | 11/2/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -138 | 27.52 | 0 | -5 | -3 | 145 | D | | | | | | | | | | | | | | |
10/11/17 19:39 | 10/10/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 5 | 0.9860 | 0 | 5 | 4 | 145 | D | | | | | | | | | | | | | | |
10/11/17 19:39 | 10/10/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -138 | 27.52 | 0 | -5 | -3 | 145 | D | | | | | | | | | | | | | | |
9/19/17 16:14 | 9/18/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 9 | 0.9860 | 0 | 10 | 7 | 145 | D | | | | | | | | | | | | | | |
9/19/17 16:14 | 9/18/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -261 | 27.51 | 0 | -10 | -6 | 145 | D | | | | | | | | | | | | | | |
8/17/17 19:45 | 8/15/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 0 | 0.00 | 0 | 12 | 9 | 145 | D | | | | | | | | | | | | | | |
8/2/17 16:42 | 8/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 0 | 0.9860 | 0 | 1 | 0 | 139 | D | | | | | | | | | | | | | | |
8/2/17 16:42 | 8/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -14 | 27.58 | 0 | -1 | 0 | 139 | D | | | | | | | | | | | | | | |
7/5/17 16:36 | 7/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 5 | 0.9860 | 0 | 5 | 4 | 139 | D | | | | | | | | | | | | | | |
7/5/17 16:36 | 7/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -145 | 29.06 | 0 | -5 | -3 | 139 | D | | | | | | | | | | | | | | |
6/5/17 19:09 | 6/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.dm | 5 | 0.9860 | 0 | 5 | 4 | 139 | M | | | | | | | | | | | | | | |
6/5/17 19:09 | 6/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.dm | -138 | 27.52 | 0 | -5 | -3 | 139 | M | | | | | | | | | | | | | | |
5/3/17 16:07 | 5/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 8 | 0.9860 | 6 | 8 | 6 | 141 | D | 125 | 31 | 5 | 13 | -1 | -1 | 2 | -2 | -1 | -1 | | | | |
5/3/17 16:07 | 5/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -269 | 33.66 | 6 | -8 | -5 | 141 | D | 125 | 31 | 5 | 13 | -1 | -1 | 2 | -2 | -1 | -1 | | | | |
4/4/17 17:38 | 4/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 8 | 0.9860 | 11 | 8 | 6 | 141 | D | 114 | 59 | 1 | 12 | 1 | -3 | -1 | -3 | 1 | 0 | -4 | | | |
4/4/17 17:38 | 4/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -268 | 33.49 | 11 | -8 | -5 | 141 | D | 114 | 59 | 1 | 12 | 1 | -3 | -1 | -3 | 1 | 0 | -4 | | | |
3/7/17 16:10 | 3/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 4 | 0.9860 | 15 | 4 | 3 | 141 | D | 132 | 68 | 18 | 26 | 34 | 29 | 14 | 11 | 2 | -2 | -7 | | | |
3/7/17 16:10 | 3/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -150 | 37.60 | 15 | -4 | -3 | 141 | D | 132 | 68 | 18 | 26 | 34 | 29 | 14 | 11 | 2 | -2 | -7 | | | |
3/2/17 19:12 | 3/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 11 | 0.9860 | 7 | 11 | | 6 | D | 111 | 53 | 10 | 5 | 18 | 20 | 1 | 3 | 6 | 6 | -2 | | | |
3/2/17 19:12 | 3/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -369 | 33.54 | 7 | -11 | -63 | 6 | D | 111 | 53 | 10 | 5 | 18 | 20 | 1 | 3 | 6 | 6 | -2 | | | |
2/3/17 16:12 | 2/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 5 | 0.9860 | 8 | 5 | 4 | 141 | D | 71 | 10 | -13 | -8 | -9 | -2 | 2 | 3 | 0 | -1 | 30 | 10 | | |
2/3/17 16:12 | 2/1/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.d | -147 | 29.35 | 8 | -5 | -3 | 141 | D | 71 | 10 | -13 | -8 | -9 | -2 | 2 | 3 | 0 | -1 | 30 | 10 | | |
1/5/17 16:01 | 1/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.dm | 8 | 0.9860 | 7 | 8 | | 6 | D | 85 | -3 | 8 | -6 | -4 | 5 | 9 | 9 | -1 | -7 | -8 | 7 | | |
1/5/17 16:01 | 1/3/17 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.dm | -249 | 31.06 | 7 | -8 | -55 | 6 | D | 85 | -3 | 8 | -6 | -4 | 5 | 9 | 9 | -1 | -7 | -8 | 7 | | |
12/2/16 16:45 | 12/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -339 | 30.80 | 9 | -11 | -7 | 141 | I | 77 | 5 | 0 | -6 | -11 | -15 | -11 | -7 | 0 | -4 | -1 | 23 | | |
11/2/16 16:13 | 11/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -343 | 31.19 | 4 | -11 | -7 | 151 | I | 104 | 10 | 27 | -6 | -9 | -6 | -7 | -2 | -6 | 1 | 0 | -5 | 6 | |
10/4/16 18:02 | 10/3/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -381 | 34.60 | 8 | -11 | -6 | 162 | I | | 38 | 56 | 17 | 6 | 10 | 1 | 3 | 1 | 2 | -10 | -12 | -3 | |
9/2/16 15:34 | 9/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -348 | 31.63 | 5 | -11 | -5 | 190 | I | | 22 | 43 | 6 | 2 | 2 | -5 | 3 | 1 | 1 | 9 | -6 | 18 | |
8/16/16 16:14 | 8/15/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | M.d | 0 | 0.00 | 7 | 3 | 2 | 201 | D | | 30 | 40 | 5 | 5 | -2 | -2 | 2 | 1 | 6 | 4 | 12 | -3 | |
8/3/16 16:56 | 8/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -365 | 33.19 | 8 | -11 | -5 | 199 | I | | 46 | 25 | 30 | 14 | 14 | 4 | -1 | -3 | -7 | -7 | -6 | -12 | |
7/6/16 16:01 | 7/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S.m | -326 | 29.62 | 15 | -11 | -5 | 214 | I | | 67 | -10 | 33 | -2 | 3 | 0 | 0 | 0 | 0 | 10 | 16 | 2 | |
6/3/16 16:01 | 6/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -347 | 31.57 | 13 | -11 | -5 | 225 | I | | 94 | 5 | 41 | 18 | 12 | 1 | -2 | 1 | -1 | -1 | 2 | 5 | |
5/3/16 16:33 | 5/2/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -226 | 25.11 | 4 | -9 | -4 | 235 | I | | 72 | -6 | -7 | 24 | 7 | -2 | 1 | -3 | -4 | 26 | 31 | 25 | |
4/5/16 12:00 | 4/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -145 | 20.69 | 5 | -7 | -3 | 244 | I | | 34 | -10 | -38 | -9 | 0 | 8 | 6 | 5 | 10 | 19 | 40 | 58 | 59 |
3/2/16 17:09 | 3/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -158 | 22.57 | 3 | -7 | -3 | 251 | I | | 38 | -17 | -25 | -12 | -7 | 1 | -3 | -6 | -7 | -11 | 38 | 36 | 49 |
2/3/16 09:27 | 2/1/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -245 | 27.25 | 5 | -9 | -3 | 255 | I | | 52 | 18 | -2 | -22 | -13 | -7 | -3 | 0 | -8 | -17 | -4 | 25 | 11 |
1/6/16 09:27 | 1/4/16 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | S | -365 | 33.17 | 8 | -11 | -4 | 264 | I | | 90 | 88 | 31 | 18 | 9 | -3 | -4 | -2 | -9 | -23 | -28 | -10 | -3 |
5/8/13 20:43 | 5/6/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 119 | 26.34 | 0 | 5 | 101 | 9 | D | | | | | | | | | | | | | | |
5/8/13 20:43 | 5/6/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -410 | 91.01 | 0 | -5 | -33 | 9 | D | | | | | | | | | | | | | | |
4/9/13 18:36 | 4/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 63 | 25.30 | 0 | 3 | 39 | 9 | D | | | | | | | | | | | | | | |
4/9/13 18:36 | 4/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -318 | 86.00 | 0 | -4 | -29 | 9 | D | | | | | | | | | | | | | | |
3/11/13 17:50 | 3/8/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 55 | 27.63 | 0 | 2 | 33 | 8 | D | | | | | | | | | | | | | | |
3/11/13 17:50 | 3/8/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -170 | 85.00 | 0 | -2 | -20 | 8 | D | | | | | | | | | | | | | | |
3/5/13 20:14 | 3/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 63 | 25.30 | 0 | 3 | 45 | 8 | D | | | | | | | | | | | | | | |
3/5/13 20:14 | 3/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -193 | 77.20 | 0 | -3 | -24 | 8 | D | | | | | | | | | | | | | | |
2/6/13 19:22 | 2/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 63 | 25.30 | 0 | 3 | 45 | 8 | D | | | | | | | | | | | | | | |
2/6/13 19:22 | 2/5/13 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -193 | 77.29 | 0 | -3 | -24 | 8 | D | | | | | | | | | | | | | | |
8/17/12 20:19 | 8/16/12 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | M.d | 253 | 25.30 | 0 | 10 | | 8 | D | | | | | | | | | | | | | | |
8/17/12 20:19 | 8/16/12 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | S.d | -824 | 68.63 | 0 | -12 | -60 | 8 | D | | | | | | | | | | | | | | |
12/3/10 18:02 | 12/1/10 | SOMX | Somaxon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | D | | S | -81 | 2.68 | 5 | -30 | -53 | 27 | D | 110 | -29 | -50 | -24 | -14 | -12 | 0 | 4 | 2 | 3 | 19 | 5 | -17 | -71 |
1/15/09 12:38 | 1/14/09 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 5 | 10.00 | 0 | 1 | 0 | 228 | | | | | | | | | | | | | | | |
11/21/08 14:20 | 11/19/08 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 2 | 3.95 | 0 | 1 | 0 | 227 | D | | | | | | | | | | | | | | |
11/12/08 13:14 | 11/10/08 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 3 | 6.00 | 0 | 1 | 0 | 227 | D | | | | | | | | | | | | | | |
8/30/07 13:48 | 8/29/07 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 39 | 38.67 | 33 | 1 | New | 1 | D | 97 | 166 | 52 | 29 | 43 | 17 | 16 | 15 | 1 | 12 | 12 | 42 | -29 | 5 |
10/2/06 17:32 | 10/2/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 43 | 10.75 | 0 | 4 | 1 | 299 | D | | | | | | | | | | | | | | |
9/22/06 13:57 | 9/21/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 21 | 10.64 | 0 | 2 | 1 | 295 | D | | | | | | | | | | | | | | |
9/20/06 17:09 | 9/19/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P.m | 43 | 10.76 | 0 | 4 | 1 | 293 | D | | | | | | | | | | | | | | |
6/2/06 17:00 | 5/31/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 55 | 4.56 | 0 | 12 | 4 | 295 | D | | | | | | | | | | | | | | |
3/3/06 13:55 | 3/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 18 | 4.56 | 0 | 4 | 1 | 282 | D | | | | | | | | | | | | | | |
3/3/06 13:55 | 3/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -64 | 16.06 | 0 | -4 | -1 | 282 | D | | | | | | | | | | | | | | |
1/17/06 14:57 | 1/13/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 9 | 4.56 | 0 | 2 | 1 | 144 | D | | | | | | | | | | | | | | |
1/17/06 14:57 | 1/13/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -58 | 14.54 | 0 | -4 | -3 | 144 | D | | | | | | | | | | | | | | |
12/19/05 15:54 | 12/15/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 11 | 4.56 | 0 | 3 | 2 | 146 | D | | | | | | | | | | | | | | |
12/19/05 15:54 | 12/15/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -59 | 14.86 | 0 | -4 | -3 | 146 | D | | | | | | | | | | | | | | |
11/17/05 13:37 | 11/15/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 9 | 4.56 | 0 | 2 | 1 | 147 | D | | | | | | | | | | | | | | |
11/17/05 13:37 | 11/15/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -53 | 13.20 | 0 | -4 | -3 | 147 | D | | | | | | | | | | | | | | |
9/1/05 19:53 | 9/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 55 | 4.56 | 0 | 12 | 9 | 149 | D | | | | | | | | | | | | | | |
9/1/05 19:53 | 9/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -382 | 19.08 | 0 | -20 | -12 | 149 | D | | | | | | | | | | | | | | |
8/3/05 14:46 | 8/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 37 | 4.56 | 0 | 8 | 5 | 157 | D | | | | | | | | | | | | | | |
8/3/05 14:46 | 8/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -371 | 18.53 | 0 | -20 | -11 | 157 | D | | | | | | | | | | | | | | |
7/5/05 17:23 | 7/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | M.d | 55 | 4.56 | 0 | 12 | 8 | 169 | D | | | | | | | | | | | | | | |
7/5/05 17:23 | 7/1/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | S.d | -349 | 17.43 | 0 | -20 | -11 | 169 | D | | | | | | | | | | | | | | |
3/15/05 21:01 | 3/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M.d | 137 | 4.56 | 0 | 30 | 20 | 178 | D | | | | | | | | | | | | | | |
3/15/05 21:01 | 3/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S.d | -831 | 27.71 | 0 | -30 | -14 | 178 | D | | | | | | | | | | | | | | |
2/8/05 15:45 | 2/7/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S | -293 | 23.46 | 0 | -13 | -6 | 180 | M | | | | | | | | | | | | | | |
11/9/04 15:14 | 11/8/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S | -340 | 27.21 | 0 | -13 | -6 | 192 | M | | | | | | | | | | | | | | |
8/10/04 16:30 | 8/9/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S | -313 | 25.05 | 0 | -13 | -6 | 195 | M | | | | | | | | | | | | | | |
6/1/04 16:22 | 5/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S.ad | -231 | 18.48 | 0 | -13 | -5 | 221 | M | | | | | | | | | | | | | | |
6/1/04 16:22 | 5/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M.ad | 9 | 4.56 | 0 | 2 | 1 | 221 | M | | | | | | | | | | | | | | |
6/1/04 16:15 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S.ad | -276 | 22.10 | 0 | -13 | -5 | 232 | M | | | | | | | | | | | | | | |
6/1/04 16:15 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M.ad | 48 | 5.29 | 0 | 9 | 4 | 232 | M | | | | | | | | | | | | | | |
5/11/04 16:38 | 5/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S.d | -194 | 18.48 | 0 | -11 | -5 | 188 | M | | | | | | | | | | | | | | |
5/11/04 16:38 | 5/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M.d | 46 | 11.52 | 0 | 4 | 2 | 188 | M | | | | | | | | | | | | | | |
4/23/04 12:45 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S.ad | -276 | 22.10 | 0 | -13 | -6 | 199 | M | | | | | | | | | | | | | | |
4/23/04 12:45 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M.ad | 48 | 5.29 | 0 | 9 | 5 | 199 | M | | | | | | | | | | | | | | |
3/11/04 16:13 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | O | P,CEO | S.d | -276 | 22.10 | 0 | -13 | -5 | 232 | M | | | | | | | | | | | | | | |
3/11/04 16:13 | 3/10/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | O | P,CEO | M.d | 36 | 4.00 | 0 | 9 | 4 | 232 | M | | | | | | | | | | | | | | |
2/19/04 16:18 | 2/17/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | O | P,CEO | M.d | 147 | 2.88 | 0 | 51 | 28 | 235 | D | | | | | | | | | | | | | | |
2/9/04 21:53 | 2/6/04 | ABGX | Abgenix Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 15 | 15.21 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
2/3/04 12:41 | 2/2/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | O | P,CEO | S.d | -329 | 21.92 | 0 | -15 | -7 | 191 | D | | | | | | | | | | | | | | |
2/3/04 12:41 | 2/2/04 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | O | P,CEO | M.d | 52 | 4.00 | 0 | 13 | 7 | 191 | D | | | | | | | | | | | | | | |
11/3/03 16:46 | 10/31/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S | -267 | 17.82 | 0 | -15 | -7 | 195 | D | | | | | | | | | | | | | | |
11/3/03 16:46 | 10/31/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M | 48 | 4.00 | 0 | 12 | 7 | 195 | D | | | | | | | | | | | | | | |
8/4/03 14:38 | 7/31/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | S | -270 | 18.01 | 0 | -15 | -7 | 203 | D | | | | | | | | | | | | | | |
8/4/03 14:38 | 7/31/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | P,CEO | M | 44 | 3.50 | 0 | 13 | 7 | 203 | D | | | | | | | | | | | | | | |